{"data":{"billId":"117-s-4152","congress":117,"type":"S","number":"4152","title":"A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.","shortTitle":null,"originChamber":"Senate","introducedDate":"2022-05-05","updateDate":"2025-12-05T10:25:56Z","latestAction":{"actionDate":"2022-05-05","text":"Read twice and referred to the Committee on Health, Education, Labor, and Pensions."},"policyArea":"Health","sponsors":[{"bioguideId":"K000377","firstName":"Mark","fullName":"Sen. Kelly, Mark [D-AZ]","isByRequest":"N","lastName":"Kelly","party":"D","state":"AZ","url":"https://api.congress.gov/v3/member/K000377?format=json"}],"cosponsorsCount":2,"committeesCount":1,"actionsCount":2,"textVersionsCount":1,"url":"https://civdotiq.org/bill/117-s-4152"},"meta":{"apiVersion":"v1","timestamp":"2026-10-03T17:08:41.558Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}